 Lille, France; Cambridge, MA; January 13, 2021 - GENFIT Nasdaq and Euronext: GNFT, a late-stage biopharmaceutical company dedicated to improving the lives of patients with metabolic and liver diseases the Company, today announces the publication in the January 13, 2021 French Bulletin des Annonces Légales Obligatoires of its convening notice for the shareholders extraordinary general meeting to be held on second notice on Monday, January 25, 2021, at 2:30 p.m. Paris time the Extraordinary General Meeting and informs holders of its bonds convertible into new shares andor exchangeable for existing shares issued by the Company on October 16, 2017 the OCEANEs of certain changes in certain of the participation and organization procedures for the meeting of the holders of the OCEANEs of January 25, 2021, at 5:30 p.m. Paris time the Bondholders Meeting. 